Neuraxis Inc. (NYSE AMERICAN: NRXS)
$2.85
-0.1650 ( -5.48% ) 5.6K
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
Market Data
Open
$2.85
Previous close
$3.01
Volume
5.6K
Market cap
$19.88M
Day range
$2.94 - $3.06
52 week range
$1.80 - $6.93
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Jul 05, 2024 |
4 | Insider transactions | 1 | Jul 02, 2024 |
4 | Insider transactions | 1 | Jul 02, 2024 |
4 | Insider transactions | 1 | Jul 02, 2024 |
def | Proxies and info statements | 6 | Jul 01, 2024 |
ars | Annual reports | 1 | Jul 01, 2024 |
pre | Proxies and info statements | 6 | Jun 21, 2024 |
8-k | 8K-related | 16 | May 28, 2024 |
10-q | Quarterly Reports | 70 | May 20, 2024 |
nt | Quarterly Reports | 1 | May 15, 2024 |